Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Tuberculin Skin Test Versus the Interferon-γ Release Assays: Out With the Old, In With the New.

Starke JR.

Pediatrics. 2020 Jan;145(1). pii: e20193021. doi: 10.1542/peds.2019-3021. No abstract available.

PMID:
31892521
2.

Multiple Cranial Tuberculomas Without Meningitis in Two Infants With Miliary Tuberculosis.

St Cyr G, Starke JR.

Pediatr Infect Dis J. 2019 Dec;38(12):e337-e339. doi: 10.1097/INF.0000000000002464.

PMID:
31738344
3.

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Nahid P, Mase SR, Migliori GB, Sotgiu G, Bothamley GH, Brozek JL, Cattamanchi A, Cegielski JP, Chen L, Daley CL, Dalton TL, Duarte R, Fregonese F, Horsburgh CR Jr, Ahmad Khan F, Kheir F, Lan Z, Lardizabal A, Lauzardo M, Mangan JM, Marks SM, McKenna L, Menzies D, Mitnick CD, Nilsen DM, Parvez F, Peloquin CA, Raftery A, Schaaf HS, Shah NS, Starke JR, Wilson JW, Wortham JM, Chorba T, Seaworth B.

Am J Respir Crit Care Med. 2019 Nov 15;200(10):e93-e142. doi: 10.1164/rccm.201909-1874ST.

4.

Fever and Knee Swelling in a 3-Year-Old Boy.

Rochat RH, Forbes LR, McKay SD, Starke JR.

Pediatr Infect Dis J. 2019 Sep;38(9):979. doi: 10.1097/INF.0000000000002305. No abstract available.

PMID:
31408058
5.

Fluid Overload and Kidney Injury Score as a Predictor for Ventilator-Associated Events.

Vaewpanich J, Akcan-Arikan A, Coss-Bu JA, Kennedy CE, Starke JR, Thammasitboon S.

Front Pediatr. 2019 May 22;7:204. doi: 10.3389/fped.2019.00204. eCollection 2019.

6.

Monitoring Treatment of Childhood Tuberculosis and the Role of Therapeutic Drug Monitoring.

Cruz AT, Starke JR.

Indian J Pediatr. 2019 Aug;86(8):732-739. doi: 10.1007/s12098-019-02882-y. Epub 2019 Feb 28. Review.

PMID:
30815840
7.

Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017.

Cruz AT, Starke JR.

Emerg Infect Dis. 2019 Mar;25(3):523-528. doi: 10.3201/eid2503.181596.

8.

Global shortages of BCG vaccine and tuberculous meningitis in children.

du Preez K, Seddon JA, Schaaf HS, Hesseling AC, Starke JR, Osman M, Lombard CJ, Solomons R.

Lancet Glob Health. 2019 Jan;7(1):e28-e29. doi: 10.1016/S2214-109X(18)30474-1. No abstract available.

9.

Treatment of tuberculosis infection in children.

Hatzenbuehler LA, Starke JR.

Expert Rev Anti Infect Ther. 2018 Sep;16(9):695-708. doi: 10.1080/14787210.2018.1513324. Epub 2018 Sep 7. Review.

PMID:
30132364
10.

Mycobacterium abscessus Infections in Children: A Review of Current Literature.

Lamb GS, Starke JR.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e131-e144. doi: 10.1093/jpids/piy047. Review.

PMID:
29897511
11.

Completion Rate and Safety of Tuberculosis Infection Treatment With Shorter Regimens.

Cruz AT, Starke JR.

Pediatrics. 2018 Feb;141(2). pii: e20172838. doi: 10.1542/peds.2017-2838.

12.

Tuberculosis in Infants and Children.

Lamb GS, Starke JR.

Microbiol Spectr. 2017 Apr;5(2). doi: 10.1128/microbiolspec.TNMI7-0037-2016. Review.

PMID:
28387193
13.

Recurrent Clostridium difficile Infection in Children: Patient Risk Factors and Markers of Intestinal Inflammation.

Nicholson MR, Crews JD, Starke JR, Jiang ZD, DuPont H, Edwards K.

Pediatr Infect Dis J. 2017 Apr;36(4):379-383. doi: 10.1097/INF.0000000000001450.

14.

Mortality in childhood tuberculosis: has there been progress?

Starke JR.

Lancet Infect Dis. 2017 Mar;17(3):239-241. doi: 10.1016/S1473-3099(16)30537-0. Epub 2016 Dec 8. No abstract available.

PMID:
27964821
15.

Increased adolescent knowledge and behavior following a one-time educational intervention about tuberculosis.

Hatzenbuehler LA, Starke JR, Smith EO, Turner TL, Balmer DF, Arif Z, Guzman F, Cruz AT.

Patient Educ Couns. 2017 May;100(5):950-956. doi: 10.1016/j.pec.2016.11.020. Epub 2016 Nov 28.

PMID:
27923675
16.

Controversies in tuberculous infection among pediatric infectious disease specialists in North America.

Cruz AT, Hersh AL, Starke JR, Beekmann SE, Polgreen PM, Banerjee R.

Int J Tuberc Lung Dis. 2016 Nov;20(11):1463-1468.

PMID:
27776586
17.

Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A.

Clin Infect Dis. 2016 Oct 1;63(7):853-67. doi: 10.1093/cid/ciw566.

18.

Angiostrongylus cantonensis Infection: A Cause of Fever of Unknown Origin in Pediatric Patients.

Foster CE, Nicholson EG, Chun AC, Gharfeh M, Anvari S, Seeborg FO, Lopez MA, Campbell JR, Marquez L, Starke JR, Palazzi DL.

Clin Infect Dis. 2016 Dec 1;63(11):1475-1478. Epub 2016 Aug 30.

PMID:
27578821
19.

Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Nahid P, Dorman SE, Alipanah N, Barry PM, Brozek JL, Cattamanchi A, Chaisson LH, Chaisson RE, Daley CL, Grzemska M, Higashi JM, Ho CS, Hopewell PC, Keshavjee SA, Lienhardt C, Menzies R, Merrifield C, Narita M, O'Brien R, Peloquin CA, Raftery A, Saukkonen J, Schaaf HS, Sotgiu G, Starke JR, Migliori GB, Vernon A.

Clin Infect Dis. 2016 Oct 1;63(7):e147-e195. doi: 10.1093/cid/ciw376. Epub 2016 Aug 10.

20.

Baseline Predictors of Treatment Outcomes in Children With Multidrug-Resistant Tuberculosis: A Retrospective Cohort Study.

Chiang SS, Starke JR, Miller AC, Cruz AT, Del Castillo H, Valdivia WJ, Tunque G, García F, Contreras C, Lecca L, Alarcón VA, Becerra MC.

Clin Infect Dis. 2016 Oct 15;63(8):1063-71. doi: 10.1093/cid/ciw489. Epub 2016 Jul 25.

PMID:
27458026
21.

Managing tuberculosis infection in children in the USA: an update.

Cruz AT, Starke JR.

Future Microbiol. 2016 May;11:669-84. doi: 10.2217/fmb-2016-0027. Epub 2016 May 10. Review.

PMID:
27164182
22.

Safety and Adherence for 12 Weekly Doses of Isoniazid and Rifapentine for Pediatric Tuberculosis Infection.

Cruz AT, Starke JR.

Pediatr Infect Dis J. 2016 Jul;35(7):811-3. doi: 10.1097/INF.0000000000001164.

PMID:
27088582
23.

School-based Study to Identify and Treat Adolescent Students at Risk for Tuberculosis Infection.

Hatzenbuehler LA, Starke JR, Graviss EA, Smith EO, Cruz AT.

Pediatr Infect Dis J. 2016 Jul;35(7):733-8. doi: 10.1097/INF.0000000000001151.

PMID:
27078123
24.

What tuberculosis can teach us about combating multidrug-resistant Gram negative bacilli.

Banerjee R, Starke JR.

J Clin Tuberc Other Mycobact Dis. 2016 Apr 1;3:28-34. doi: 10.1016/j.jctube.2016.03.004. eCollection 2016 May.

25.

Laboratory Diagnosis of Mycobacterium tuberculosis Infection and Disease in Children.

Dunn JJ, Starke JR, Revell PA.

J Clin Microbiol. 2016 Jun;54(6):1434-1441. doi: 10.1128/JCM.03043-15. Epub 2016 Mar 16. Review.

26.

Extensively drug-resistant tuberculosis in a young child after travel to India.

Salazar-Austin N, Ordonez AA, Hsu AJ, Benson JE, Mahesh M, Menachery E, Razeq JH, Salfinger M, Starke JR, Milstone AM, Parrish N, Nuermberger EL, Jain SK.

Lancet Infect Dis. 2015 Dec;15(12):1485-91. doi: 10.1016/S1473-3099(15)00356-4. Epub 2015 Nov 16. Review.

27.

Clinical Case Definitions for Classification of Intrathoracic Tuberculosis in Children: An Update.

Graham SM, Cuevas LE, Jean-Philippe P, Browning R, Casenghi M, Detjen AK, Gnanashanmugam D, Hesseling AC, Kampmann B, Mandalakas A, Marais BJ, Schito M, Spiegel HM, Starke JR, Worrell C, Zar HJ.

Clin Infect Dis. 2015 Oct 15;61Suppl 3:S179-87. doi: 10.1093/cid/civ581.

28.

New Diagnostics for Childhood Tuberculosis.

Chiang SS, Swanson DS, Starke JR.

Infect Dis Clin North Am. 2015 Sep;29(3):477-502. doi: 10.1016/j.idc.2015.05.011. Epub 2015 Jul 16. Review.

PMID:
26188605
29.

Risk Factors for Community-associated Clostridium difficile-associated Diarrhea in Children.

Crews JD, Anderson LR, Waller DK, Swartz MD, DuPont HL, Starke JR.

Pediatr Infect Dis J. 2015 Sep;34(9):919-23. doi: 10.1097/INF.0000000000000767.

30.

When the Health Care Worker Is Sick: Primum Non Nocere.

Starke JR, Jackson MA.

JAMA Pediatr. 2015 Sep;169(9):809-10. doi: 10.1001/jamapediatrics.2015.0994. No abstract available.

PMID:
26148244
31.

Ebola Knowledge and Attitudes Among Pediatric Providers Before the First Diagnosed Case in the United States.

Highsmith HY, Cruz AT, Guffey D, Minard CG, Starke JR.

Pediatr Infect Dis J. 2015 Aug;34(8):901-3. doi: 10.1097/INF.0000000000000755.

PMID:
26020407
32.

Persistent cat scratch disease requiring surgical excision in a patient with MPGN.

King KY, Hicks MJ, Mazziotti MV, Eldin KW, Starke JR, Michael M.

Pediatrics. 2015 Jun;135(6):e1514-7. doi: 10.1542/peds.2014-2923. Epub 2015 May 11.

33.

A teenager with fever, rash, and arthralgia. Streptobacillus moniliformis infection.

Crews JD, Palazzi DL, Starke JR.

JAMA Pediatr. 2014 Dec;168(12):1165-6. doi: 10.1001/jamapediatrics.2014.1604. No abstract available.

PMID:
25436846
34.

Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children.

Starke JR; Committee On Infectious Diseases.

Pediatrics. 2014 Dec;134(6):e1763-73. doi: 10.1542/peds.2014-2983. Review.

PMID:
25422024
35.

A hospital-based study of the clinical characteristics of Clostridium difficile infection in children.

Crews JD, Koo HL, Jiang ZD, Starke JR, DuPont HL.

Pediatr Infect Dis J. 2014 Sep;33(9):924-8. doi: 10.1097/INF.0000000000000338.

36.

Improving tuberculosis care for children in high-burden settings.

Starke JR.

Pediatrics. 2014 Oct;134(4):655-7. doi: 10.1542/peds.2014-1652. Review. No abstract available.

PMID:
25266434
37.

Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in children.

Cruz AT, Starke JR.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1057-61. doi: 10.5588/ijtld.14.0286.

PMID:
25189552
38.

Performance of the QuantiFERON-TB gold interferon gamma release assay among HIV-infected children in Botswana.

Cruz AT, Marape M, Graviss EA, Starke JR.

J Int Assoc Provid AIDS Care. 2015 Jan-Feb;14(1):4-7. doi: 10.1177/2325957414547432. Epub 2014 Aug 22.

PMID:
25149414
39.

Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis.

Chiang SS, Khan FA, Milstein MB, Tolman AW, Benedetti A, Starke JR, Becerra MC.

Lancet Infect Dis. 2014 Oct;14(10):947-57. doi: 10.1016/S1473-3099(14)70852-7. Epub 2014 Aug 6. Review.

PMID:
25108337
40.

What's in a number? Accurate estimates of childhood tuberculosis.

Cruz AT, Starke JR.

Lancet Glob Health. 2014 Aug;2(8):e432-3. doi: 10.1016/S2214-109X(14)70269-4. Epub 2014 Jul 8. No abstract available.

41.

Tuberculosis exposure, infection and disease among children with medical comorbidities.

Cruz AT, Merchant O, Zafar A, Starke JR.

Pediatr Infect Dis J. 2014 Aug;33(8):885-8. doi: 10.1097/INF.0000000000000343.

PMID:
24642517
42.

Tuberculosis in pediatric oncology and bone marrow transplantation patients.

Cruz AT, Airewele G, Starke JR.

Pediatr Blood Cancer. 2014 Aug;61(8):1484-5. doi: 10.1002/pbc.24985. Epub 2014 Feb 20.

PMID:
24623644
43.

The global nature of childhood tuberculosis.

Starke JR, Cruz AT.

Pediatrics. 2014 Mar;133(3):e725-7. doi: 10.1542/peds.2013-4139. Epub 2014 Feb 10. No abstract available.

PMID:
24515521
44.

Disseminated tuberculosis in 2 children with inflammatory bowel disease receiving infliximab.

Cruz AT, Karam LB, Orth RC, Starke JR.

Pediatr Infect Dis J. 2014 Jul;33(7):779-81. doi: 10.1097/INF.0000000000000286.

PMID:
24469071
45.

Relationship between tuberculin skin test (TST) size and interferon gamma release assay (IGRA) result: when should clinicians obtain IGRAs in children with positive TSTs?

Cruz AT, Starke JR.

Clin Pediatr (Phila). 2014 Oct;53(12):1196-9. doi: 10.1177/0009922813515743. Epub 2013 Dec 23. No abstract available.

PMID:
24367000
46.

Common presentations of nontuberculous mycobacterial infections.

Hatzenbuehler LA, Starke JR.

Pediatr Infect Dis J. 2014 Jan;33(1):89-91. doi: 10.1097/INF.0000000000000170. Review. No abstract available.

PMID:
24346597
47.

Old and new approaches to diagnosing and treating latent tuberculosis in children in low-incidence countries.

Cruz AT, Starke JR, Lobato MN.

Curr Opin Pediatr. 2014 Feb;26(1):106-13. doi: 10.1097/MOP.0000000000000049. Review.

48.

Treatment of Latent Tuberculosis Infection in Children.

Cruz AT, Ahmed A, Mandalakas AM, Starke JR.

J Pediatric Infect Dis Soc. 2013 Sep;2(3):248-58. doi: 10.1093/jpids/pit030. Epub 2013 May 19.

PMID:
26619479
49.

A review of the neurological and neurosurgical implications of tuberculosis in children.

Vadivelu S, Effendi S, Starke JR, Luerssen TG, Jea A.

Clin Pediatr (Phila). 2013 Dec;52(12):1135-43. doi: 10.1177/0009922813493833. Epub 2013 Jul 10. Review.

PMID:
23847176
50.

Gastric Aspirate Yield For Children With Suspected Pulmonary Tuberculosis.

Cruz AT, Revell PA, Starke JR.

J Pediatric Infect Dis Soc. 2013 Jun;2(2):171-4. doi: 10.1093/jpids/pis089. Epub 2012 Sep 19.

PMID:
26619464

Supplemental Content

Loading ...
Support Center